mDR Ltd - 16 Dec 2024 SCHEDULE 13G/A Report for CytoMed Therapeutics Ltd Ordinary Shares, no par value per share (GDTC)

Filing Manager: mDR Ltd
Reporting Manager: mDR LTD
Security: CytoMed Therapeutics Ltd Ordinary Shares, no par value per share
Symbol: GDTC
Shares outstanding: 11,543,981 shares
Disclosed Ownership: 1,307,933 shares
Ownership: 11%
Form type: SCHEDULE 13G/A
Filing time: 24 Mar 2025, 12:01:24 UTC
Date of event: 16 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
mDR LTD	11%	1,307,933	1,307,933	0	/s/ Edward Lee Ewe Ming	Executive Chairman